A Review on Mouth Dissolving Tablet

 

Darshan Khairnar*, Rajendra Surawase, Lalit Gangurde, Rakesh Wagh, Akshay Aher

Department of Pharmaceutics, Dr. J. D. Pawar College of Pharmacy, Manur, Tal - Kalwan

Dist. - Nashik 423501, Maharashtra, India.

*Corresponding Author E-mail: darshankhairnar7801@gmail.com

 

ABSTRACT:

Mouth dissolving tablet by resolving earlier administration issues and extending patent life, mouth dissolving tablets have gained a significant market share. When Mouth Dissolving Tablets come into touch with saliva, they have the unusual ability to dissolve and release the medication quickly.1 MDTs are tablets that dissolve quickly in saliva when taken in the mouth, requiring no additional liquid and allowing for swallowing. Specifically, the European Pharmacopoeia used the term "Oro dispersible tablet" for MDTs. Other names for mouth disintegrating pills are melt-in-mouth tablet Orodispersible tablets, rapid dissolving/dispersing tablets, and quick melting tablets. The potential advantages of MDTs as an oral medication delivery method for a range of individuals with various illnesses and impairments are reviewed in this article. Mouth dissolving tablets were created to solve the problems with traditional dosage forms. They offer good hardness, dose homogeneity, and convenience of administration. They are the preferred dosage form for elderly, paediatric, and travel patients. More sophisticated oral drug delivery systems have long piqued the curiosity of researchers looking for ways to increase patients' compliance with their prescription regimens. Mouth-dispensing drug delivery systems (MDDDS) have taken the lead in the market by removing administration issues and prolonging the patent life.

 

KEYWORDS: Mouth dissolving tablet, Methods for Making and Evaluating Mouth-Dissolving Tablets (MDTs), Superdisintegrants.

 

 


INTRODUCTION:

Oral tablets that break down upon contact with saliva, fast-dissolve tablets, and other similar terminology describe solid dose forms that dissolve or disintegrate quickly in the mouth without the use of water. For people who have problems swallowing traditional pills, this greatly simplifies dosing.1-2 Drug distribution relies heavily on mouth dissolving tablets for a number of reasons.

 

1. Patient Convenience: They offer a dose form that is simple to swallow, which is particularly beneficial for patients who have trouble swallowing, such as young children, the elderly, and those with certain medical conditions. 3

2. Quick Onset of Action: Because mouth-dissolving pills dissolve or disintegrate so quickly in the mouth, they can be absorbed into the bloodstream more quickly. 4 This can lead to a quicker onset of action than with traditional oral dosage forms, which is excellent for treatments that need to take effect right away, such painkillers and anxiety medications. 5.

 

3. Better Compliance: Patients are more likely to adhere to their prescription regimens because they are tasty and easy to chew, which enhances treatment outcomes and lowers the possibility of missing doses6.

 

4. Precise Dosage: Mouth dissolving tablets are made to administer exact dosages of medicine, guaranteeing regular dosing and lowering the possibility of dosing mistakes7.

 

5. Improved Bioavailability: Because mouth-dissolving tablets dissolve and absorb more readily in the oral cavity, several medications may have better bioavailability when taken in this manner8.

 

6. Stability: Because mouth dissolving tablets are frequently less prone to deterioration from moisture or temperature variations, they can provide better stability and shelf life when compared to other dosage forms9.

 

All things considered, mouth dissolving tablets offer a flexible and efficient drug delivery solution that meets patient needs and has benefits in terms of ease of use, effectiveness, and adherence10.

 

Perfect qualities:11

An optical MDT should:

1.    Not require water when administered orally.

2.    Feel good in your mouth.

3.    Possess a passable ability to disguise flavour.

4.     Be less friable and tougher.

5.    After administration, leave little to no residue in the mouth.

6.    Show minimal susceptibility to external factors, such as humidity and temperature

7.    Permit the production of tablets using standard processing and packaging tools.

 

Benefits:12

1.    Giving medication to those who have trouble swallowing, such as the elderly, bedridden patients, people with renal failure, and people who are unable to swallow, such children, the old, and people with mental illnesses.

2.    Quick intervention with medication treatment.

3.    Pre-gastric absorption of medications from the mouth, throat, and oesophagus as saliva flows down allows for improved bioavailability and quick absorption.

4.    Easy to administer and patient-compliant for bedridden, impaired patients as well as for busy individuals and travellers who don't always have access to water.

5.    By avoiding physical blockage, when standard formulations are administered orally, there is less chance of choking or suffocating, increasing safety.

6.    The product distinction will lead to the creation of new business opportunities.

 

Mouth-dispersing tablet limitations13

1.    Typically, the tablets' mechanical strength is inadequate. Careful handling is therefore necessary.

2.    Inadequate formulation of the pills may result in an unpleasant taste and/or grittiness in the mouth.

3.    Formulating medications with comparatively higher dosages into MDT is challenging. For example, antibiotics like as ciprofloxacin come in adult dose tablets that contain around 500mg of the medication.

4.    MDT may not be the ideal option for patients who are also using anticholinergic drugs. Similarly, these pill formulations might not be suitable for people who have dry mouth from reduced saliva production.

5.    Mouth dissolving pills are more susceptible to moisture than regular oral tablets. Their design and composition, which frequently incorporates water-soluble excipients and quick disintegration qualities, are the cause of this sensitivity.

There are Several Methods for Creating Mouth-Disintegrating Medication Delivery Devices.13

1.    Lyophilization technology (freeze-drying)

2.    Sublimation methods

3.    The use of spray drying methods

4.    Mass extrusion technique is the fourth

5.    The direct compression technique

6.    Applying disintegrates

 

1)    Lyophilization Technology (freeze-drying):

a method by which, after freezing, water is sublimated from the product. A pharmaceutical technique called lyophilization enables the low-temperature drying of biologicals and heat-sensitive medications in a way that permits the sublimation of water. Preparations produced by lyophilization have a very high specific surface area, are very porous, dissolve quickly, and exhibit enhanced absorption and bioavailability. R. P. Scherer invented Zydis technology, a mouth-dissolving tablet made by a freeze-drying process. Seager talked about the creation, technique, technology, and bioavailability of fast-dissolving tablets made with Zydis technology.14

 

Advantages:

1.    Preserves nutrients and flavor

2.    Long shelf life

3.    Lightweight

4.    Easy to reconstitute

 

Disadvantages:

1)    Expensive equipment

2)    Time-consuming process

3)    Sensitive to temperature and humidity

4)    Llimited availability

5)    Not suitable for all products

 

2) Sublimation Methods:

Water-soluble components are used to create moulded tablets, which dissolve or disintegrate quickly and thoroughly. A hydroalcoholic solvent is used to wet the powder before it is moulded into tablets with less pressure than in a traditional dosage form. The process of air-drying eliminates the solvents. Because to its porous nature, the tablet dissolves easily. Including PVP K30, acacia, or sugar may improve the tablet's mechanical strength.15-16

 

Advantages:

1.    Improved bioavailability

2.    Increased dissolution rate

3.    Low temperature process

 

Disadvantages:

1.    Expensive equipment

2.    Requires careful process control

3.    Limited scalability

 

3) The Use of Spray Drying Methods:

One method for creating very porous, tiny particles is pray drying. The pharmaceutical sector always uses spray-dryers to create very porous powders. This method has been used to produce fast-dissolving tablets, according to Allen et al. Rapidly dissolving tablets can be made by spray drying. The foundation of this technique is a particulate support matrix, which is spray-dried and combined with other materials to form an aqueous composition, resulting in a tiny, extremely porous powder. After that, the active component is combined with this and compacted into a tablet. The spray drying method was used to create the fast-dissolving tablet, which broke up in 20 seconds.15-16

 

Advantages:

1.    Fast drying time

2.    High-quality powder

3.    Flexibility

 

Disadvantages:

1.    High energy costs

2.    Risk of over-drying

3.    Requires skilled operatore

 

Key Requirements for the Excipients Utilised in Mdts Formulation17

1.    It must have a rapid disintegration rate.

2.    The MDTs shouldn't be impacted by their particular characteristics.

3.    It shouldn't interfere with other excipients or medications.

4.    It shouldn't affect the product's organoleptic qualities or effectiveness.

5.    The final stability and integrity of the product must be considered when choosing a binder (either a single binder or a combination of binders).

6.    The excipients utilized will have melting points between 30 and 350 degrees Celsius.

7.    Liquid, semi-liquid, solid, or polymeric mixtures can contain the binders.

8.    (For example, hydrogenated vegetable oils, coca butter, and polyethylene glycol).17

 

Blend Evaluation Using the Following Techniques, The Created Mix Was Evaluated.

1.    The angle of rest

2.    Density of bulk

3.    Density that is taped

4.    The index of Carr's compressibility

5.    The Hausner ratio

 

Mdt Quality Control Evaluative:

The following quality control tests were performed on tablets made using each of the formulas: Customers' overall appearance:

 

A tablet's size, form, taste, colour, physical defects, surface texture, consistency, and readability of any identifying markings all affect how people perceive its overall look, visual identity, and degree of "elegance."

 

Size and shapeL:

In terms of its dimensions, the tablet's size and shape may be controlled and monitored.18

 

Tablet's Thickness:

Certain filling devices employ the tablets' constant thickness as a counting mechanism.  A micrometre or a Vernier calliper can be used to measure the tablet's thickness, much as with regular tablets. It is possible to take ten pills and test their thickness using a micrometre.19

 

Friability:

One tool for determining friability is the Roche Friabilator. A tablet may fall from a height of 6 inches with each rotation of this apparatus, which rotates the plastic container at a pace of 25 revolutions per minute. The tablet is exposed to the combined effects of abrasion and tension throughout this process. The friabilator is used to evaluate a batch of pills that have been weighed 100 times beforehand.20

 

Time spent wetting:

There is a relationship between the dosage form's contact angle and wetting time. The disintegration qualities of tablets must be evaluated; a shorter wetting time indicates a faster rate of breakdown. A tablet is placed in a tiny Petri dish that is 6.5 cm in diameter, 6ml of water is added, and the time it takes for the tablet to get totally wet is measured.21

 

Test of disintegration: Since fast-dissolving tablets must disintegrate without water in order for the test to be correct, their disintegration times must be modified. For this, a 10cm diameter Petri dish is filled with 10 ml of water. The tablet is carefully positioned in the middle of the Petri dish, and the amount of time it takes for it to completely crumble into small bits is visible.22

 

Ratio of Water Absorption:

You can fold a piece of tissue paper twice and put it in a tiny Petri dish with six millilitres of water. By arranging it on paper, you may determine how long it will take for the a tablet to get totally wet. The wet tablet is then weighed.23

 

Time of in Vitro Dispersion:

A tablet is dropped into a beaker containing 50 millilitres of liquid to determine the in vitro dispersion time. To conduct an in vitro dispersion test, we select three tablets at random from each formulation. The amount of time it takes for a pill to dissolve entirely may be measured.23

 

In Vitro Dissolution Test:

The USP paddle method, operating at 50 revolutions per minute in 900 milliliters of a dissolving medium maintained at a temperature of 37±0.5 degrees Celsius, can be employed for in vitro dissolution studies A dissolving media can be chosen depending on the amonograph. The sample should be removed at certain intervals following staining via Whatman filter paper and spectrophotometric measurement at a particular wavelength. After every sampling, the same volume of newly heated medium (37°C) is introduced back into the dissolving media to keep the volume constant throughout the test. Dissolution investigations are carried out using n=6.24

 

Future Perspectives:

1.    Personalised medication: By integrating patient-specific data, such age, weight, and medical history, MDT tablets may be made to offer personalised treatment.

2.    Targeted delivery: To increase effectiveness and lessen adverse effects, MDT tablets can be made to target particular bodily locations, such the stomach or intestines.

3.    Combination products: To create a thorough treatment plan, MDT tablets can be used in conjunction with other dosage forms including injectables or transdermal patches.

4.    Digital health integration: To track patient adherence and treatment results, MDT tablets can be used with digital health technology like wearables or smartphone apps.

5.    Sustainabilit: By utilising eco-friendly materials, cutting down on packaging waste, and encouraging ecologically conscious production techniques, MDT tablets may be made to be more sustainable.

6.    Point-of-care diagnostics: Patients may self-test and get therapy right away using MDT tablets that include point-of-care diagnostics.

7.    3D printing: MDT tablets may be produced with 3D printing technology, which enables complicated dosage form design, personalised treatment, and quick prototyping.

 

CONCLUSION:

One of the most innovative approaches in the pharmaceutical sector is the use of MDF formulations, which have the potential to become one of the most effective dosage forms for the treatment of diseases or disorders in the future. These novel formulations are safer, more effective, and have higher patient acceptability and compliance than conventional formulations. MDF improves treatment responsiveness and provides a number of advantages. When an immediate initiation of action is required, such as in emergency situations like allergic responses and asthmatic crises, MDF are crucial. MDF is now a validated and widely used technique for the systemic administration of APIs for both prescription and over-the-counter (OTC) pharmaceuticals, as well as those in the early to mid-stage phases of research.

 

REFERENCES:

1.     Prajapati, S. T., Patel, L. D., and Patel, D. M. Orally disintegrating tablets: A review. Tropical Journal of Pharmaceutical Research, 2014;13(8): 1259 1272.

2.      B. S. Kuchekar, S. B. Bhise and V. Arumugam. Design of Fast Dissolving Tablet. Indian Journal of Pharmaceutical Education. 2001; 35(4): 150-152.

3.      Vosgerau, M. Z., and Nørgaard, L. S. Risk of respiratory morbidity in the offspring of pregnant women with autoimmune hepatitis: A population-based cohort study. Liver International. 2021; 41(1): 103-109.

4.     Prabhu P, et al. Orally Disintegrating Tablets: A Review. International Journal of Pharmaceutical Sciences and Nanotechnology. 2010; 3(1): 795 804.

5.     Bhagwat DA, et al. Formulation and evaluation of mouth dissolving tablets: A review. International Journal of Research in Pharmacy and Chemistry. 2011; 1(3): 498-508.

6.     Sharma, Divya, and Monica Sonkhla. Mouth Dissolving Tablets: A Review. Journal of Drug Delivery and Therapeutics. 2019; 9(1): 428-433.

7.     Kumar, A., et al. Mouth dissolving tablets: A novel drug delivery system. Pharma Science Monitor. 2011: 175-188.

8.     Dey, N., et al. Oral Disintegrating Tablets: A Review. Journal of Drug Delivery and Therapeutics. 2019; 9(2): 711-716.

9.     Sharma D, Singh S, Kumar D. Formulation and evaluation of mouth dissolving tablets of sumatriptan succinate. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(3): 208-214.

10.   Senthil, V., Nithya, R., and Pandiyan, V. Mouth Dissolving Tablets: A Review. Journal of Drug Delivery and Therapeutics. 2016; 6(5): 15 21.

11.   Sahoo S, Mishra B, Biswal P, Panda O, Mahapatra S, Jana G. Fast Dissolving Tablet: As A Potential Drug Delivery System. Drug Invention. 2010; 2(2): 130-135.

12.   Kaur T, Gill B, Kumar S, Gupta G. Mouth Dissolving Tablets: A Novel Approach to Drug Delivery. International Journal of Current Pharmaceutical Research. 2011; 3(1); 1-7.

13.   Nayak U, Patra S, Rout P, Patro B, Nayak B. Development and optimization of prometazine theoclate Mouth dissolving tabltes. The Indian Pharmacist. 2008; 4: 65-68.

14.   Gregory G, Ho D, U.S. Patent 4, 305,502 (1981).

15.   B. S. Kuchekar, S. B. Bhise and V. Arumugam. Design of Fast Dissolving Tablet. Indian Journal of Pharmaceutical Education. 2001; 35(4): 150-152.

16.   Bhushan Y, Sambhaji S, Anant R, Kakasaheb R. New drug delivery system for elderly. Indian Drugs. 2000; 37; 312-318.

17.   Rangasamy Manivannan - Oral Disintegrating Tablets: A Future Compaction. IJPRD. 2009; 1(10): 5.

18.   Deshpande RD, Gowda DV, Mahammed N, Maramwar DN. Bi-layertablets-an emerging trend: A review. Int J Pharm Sci Res. 2011; 2: 2534.

19.   Kumar AH, Kavitha K, Kumar SA, Kumar MR, Singh SD. Novel approach of bilayer tablet technology-a review. Int J Pharm Chem Biol Sci. 2013; 3: 887-93.

20.   Prajapati BG, Patel B. Formulation, evaluation and optimizationof orally disintegrating tablet of piroxicam. Int J Pharm Tech Res., 2010; 2: 1893-9.

21.   Manivannan R. Oral disintegrating tablets: A future compaction. Drug Invent Today. 2009; 1: 61-5.

22.   Mangal M, Thakral S, Goswami M, Thakur N. Comparison studybetween various reported disintegrating methods for fast dissolvingtablets. Afr J Basic Appl Sci. 2012; 4: 106-9.

23.   Allam A, Fetih G. Sublingual fast dissolving niosomal films forenhanced bioavailability and prolonged effect of metoprolol tartrate. Drug Des Dev Ther. 2016; 10: 2421-33. doi: 10.2147/DDDT.S113775  

24.   Ige P, Swami B, Patil T, Pradhan J, Patil P, Nerkar P, et al. Design and development of sustained release swelling matrix tablets.

 

 


 

 

Graphical Abstract

Mouth Dissolving Tablet

 

 

 

Received on 08.03.2025      Revised on 10.04.2025

Accepted on 05.05.2025      Published on 09.05.2025

Available online from May 12, 2025

Res.  J. Pharma. Dosage Forms and Tech.2025; 17(2):102-106.

DOI: 10.52711/0975-4377.2025.00015

©AandV Publications All Right Reserved

 

This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License.